Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

#3-Smiley Riley(#698510) -From your link (thank yo

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153932
(Total Views: 736)
Posted On: 12/27/2020 11:09:32 PM
Posted By: smurph
Re: smurph #69892
#3-Smiley Riley(#698510) -From your link (thank you)

"So critical care patients can get eIND's if they aren't at one of the clinical trial sites. All the doctors in the current sites should get their patients enrolled ASAP. What makes this announcement so powerful is that the doctors in this study were blinded. They thought it was working but after they enroll a couple of patients they will know it is working and this word will spread like wild fire. I expect patient recruitment to go through the roof next week.
"This impending EUA / outright approval is long overdue. With over 100 miraculous EIND stories, 5 trials for Mild/Moderate & Severe Critical, 2 publications, countless 'ambassadors of Leronlimab or Vyrologix its brand name including the likes of Dr Bruce Patterson among many others.

"To anyone with a loved one in the hospital with Covid19 or suffering from Covid Longhaulers symptoms I highly suggest asking your doctor for this incredible monoclonal antibody treatment. This therapy targets the CCR5 cell and reduces the viral load in days! I strongly believe it should have gotten approval by NIH, OWS and FDA many months ago as it concluded MM trials in May.
Not going to get into political corruption theory here but Big Pharma came first w 3 drugs that don't work. Read into it what you will. Many stories will be written about this in the months to come. God only knows how many lives could have been saved had Leronlimab been allowed to go to market back in June...just around the time that Gileads Remdesivir trumped over CytoDyns Leronlimab....hmm, very odd eh. Remdesivir was ruled by OWS as ineffective for those unaware.


(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us